Goldman Sachs’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-37,525
Closed -$3.32M 5658
2023
Q3
$3.32M Buy
37,525
+17,724
+90% +$1.74M ﹤0.01% 3351
2023
Q2
$1.98M Buy
19,801
+16,002
+421% +$1.59M ﹤0.01% 3883
2023
Q1
$365K Buy
+3,799
New +$381K ﹤0.01% 5007
2022
Q2
Sell
-6,294
Closed -$821K 6495
2022
Q1
$821K Buy
+6,294
New +$749K ﹤0.01% 4984

Other funds holding CURE

Goldman Sachs's CURE Position: Q4 2023 in Review

Goldman Sachs sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q4 2023, closing a stake of 37,525 shares — an estimated $3.32M sold.

Goldman Sachs first reported a position in CURE in Q1 2022 and held it in 4 quarters. The position peaked at $3.32M in Q3 2023. 20 funds tracked by Wall St. Rank hold CURE as of Q4 2023.

  • Goldman Sachs reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q4 2023 after selling out during the quarter.
  • Goldman Sachs sold 37,525 Direxion Daily Healthcare Bull 3X ETF shares in Q4 2023, an estimated $3.32M.
  • Goldman Sachs first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q1 2022 and held it in 4 quarters.
  • Goldman Sachs's Direxion Daily Healthcare Bull 3X ETF position peaked at $3.32M in Q3 2023.
  • 20 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q4 2023.

Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.